Galera Therapeutics' Angel - III Round

Galera Therapeutics raised a round of funding on March 11, 2011. Investors include St. Louis Arch Angels.

Galera Therapeutics is a clinical-stage biotechnology company, headquartered in Malvern, PA, focused on the development of drugs targeting oxygen metabolic pathways. The Company's lead compounds are h…

Articles about Galera Therapeutics' Angel - III Round: